Evidence map›Paper›PMID 38953940›Full record

ArticlePsychopharmacology2024

Sex differences in behavior, cognitive, and physiological recovery following methamphetamine administration.

Monserrat Armenta-Resendiz, Jordan S Carter, Zachariah Hunter, Makoto Taniguchi, Carmela M Reichel, Antonieta Lavin

Abstract read
In one paragraph

Article in Psychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. The use ofFrontiers in cell and developmental biology · 2026
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Monserrat Armenta-Resendiz *Department of Neuroscience, MUSC, 173 Ashley Ave 403BSB, Charleston, SC, 29425, USA.
Jordan S Carter *Department of Neuroscience, MUSC, 173 Ashley Ave 403BSB, Charleston, SC, 29425, USA.
Zachariah HunterDepartment of Neuroscience, MUSC, 173 Ashley Ave 403BSB, Charleston, SC, 29425, USA.
Makoto TaniguchiDepartment of Neuroscience, MUSC, 173 Ashley Ave 403BSB, Charleston, SC, 29425, USA.
Carmela M ReichelDepartment of Neuroscience, MUSC, 173 Ashley Ave 403BSB, Charleston, SC, 29425, USA.
Antonieta LavinDepartment of Neuroscience, MUSC, 173 Ashley Ave 403BSB, Charleston, SC, 29425, USA. lavina@musc.edu.ORCID http://orcid.org/0000-0002-0056-7862

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
The Impact of Stress and Craving on Return to Postpartum Cannabis UseU54DA016511 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KATHLEEN T. BRADY · 2018 to 2026
$15.9M
COCA: Project 4. Neurocircuit Strategy to Decrease Cocaine Cue ReactivityP50DA046373 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCGINTY, JACQUELINE F. · 2019 to 2023
$9.9M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
Corticostriatal Neuroplasticity and Cognition in Methamphetamine AddictionR01DA033049 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SCOFIELD, MICHAEL DAVID · 2012 to 2022
$3.4M
Methamphetamine Effects on Prefrontal Cortical PV+ Interneurons and Resulting Cognitive DeficitsR01DA054589 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LAVIN, ANTONIETA · 2021 to 2025
$1.9M
Establishing sex-specific mechanisms for estrogen receptor beta in heroin extinction memory recallF30DA057044 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CARTER, JORDAN SCOTT · 2023 to 2024
$80k
National Institute of Mental Health and Neurosciences R01 129521NCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450NIDA NIH HHS F30 DA057044NIDA NIH HHS P50 DA046373NIDA NIH HHS R01 DA033049NIDA NIH HHS R01 DA054589NIDA NIH HHS U54 DA016511
6 · The paper itself

Abstract

Intact executive functions are required for proper performance of cognitive tasks and relies on balance of excitatory and inhibitory (E/I) transmission in the medial prefrontal cortex (mPFC). Hypofrontality is a state of decreased activity in the mPFC and is seen in several neuropsychiatric conditions, including substance use disorders. People who chronically use methamphetamine (meth) develop hypofrontality and concurrent changes in cognitive processing across several domains. Despite the fact that there are sex difference in substance use disorders, few studies have considered sex as a biological variable regarding meth-mediated hypoactivity in mPFC and concurrent cognitive deficits. Hypofrontality along with changes in cognition are emulated in rodent models following repeated meth administration. Here, we used a meth sensitization regimen to study sex differences in a Temporal Order Memory (TOM) task following short (7 days) or prolonged (28 days) periods of abstinence. GABAergic transmission, GABAA receptor (GABA

Indexed as

Central Nervous System StimulantsCognitionMethamphetaminePrefrontal CortexReceptors, GABA-ASex CharacteristicsAnimalsBehavior, AnimalFemaleGABA Plasma Membrane Transport ProteinsMaleRatsRats, Sprague-DawleySex FactorsCentral Nervous System StimulantsGABA Plasma Membrane Transport ProteinsMethamphetamineReceptors, GABA-AGABAHypofrontalityMethamphetaminesex differences

Identifiers

PMID38953940
PMCPMC11513735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.